Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accounts Payables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Accounts Payables for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 548.7% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 548.7% year-over-year, with the annual reading at $1.5 million for FY2025, 548.7% up from the prior year.
  • Accounts Payables for Q4 2025 was $1.5 million at Catheter Precision, up from $1.1 million in the prior quarter.
  • The five-year high for Accounts Payables was $1.5 million in Q4 2025, with the low at $92000.0 in Q4 2022.
  • Average Accounts Payables over 5 years is $681052.6, with a median of $647000.0 recorded in 2025.
  • The sharpest move saw Accounts Payables plummeted 90.69% in 2022, then surged 789.25% in 2024.
  • Over 5 years, Accounts Payables stood at $988000.0 in 2021, then tumbled by 90.69% to $92000.0 in 2022, then skyrocketed by 404.35% to $464000.0 in 2023, then tumbled by 50.43% to $230000.0 in 2024, then skyrocketed by 548.7% to $1.5 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $1.5 million, $1.1 million, and $804000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.